Animal models of depression

Animal models of depression are research tools used to investigate depression and action of antidepressants as a simulation to investigate the symptomatology and pathophysiology of depressive illness or used to screen novel antidepressants.

Introduction

Depression

Major depressive disorder, also called "clinical depression" or often simply "depression", is a common, long-lasting and diverse psychiatric syndrome that significantly affects a person's thoughts, behavior, feelings and sense of well-being. Symptoms include low mood and aversion to activity. Depressed people may also feel sad, anxious, empty, hopeless, worried, helpless, worthless, guilty, irritable, hurt, or restless. They may lose interest in activities that once were pleasurable, experience loss of appetite or overeating, have problems concentrating, remembering details, or making decisions, and may contemplate or attempt suicide. Insomnia, excessive sleeping, fatigue, loss of energy, or aches, pains, or digestive problems that are resistant to treatment may also be present.[1]

About one in six people in the U.S will succumb to depression at some point during their life span,[2] and according to the World Health Organization, depression is projected to reach second place as leading contributor to the global burden of disease by the year 2020.[3] The current antidepressants have late drug efficacy about 3–6 weeks; besides, many patients’ illness cannot be alleviated.[4]

Modeling depression in animals

It is difficult to develop an animal model that perfectly reproduces the symptoms of depression in patients. Many animals lack self-consciousness, self-reflection, and consideration; moreover, hallmarks of the disorder such as depressed mood, low self-esteem or suicidality are hardly accessible in non-humans. However, depression, as other mental disorders, consists of endophenotypes[5] that can be reproduced independently and evaluated in animals. An ideal animal model offers an opportunity to understand molecular, genetic, and epigenetic factors that may lead to depression. By using animal models, the underlying molecular alterations and the causal relationship between genetic or environmental alterations and depression can be examined, which would afford a better insight into pathology of depression. In addition, animal models of depression are indispensable for identifying novel therapies for depression.

Endophenotypes in animal model of depression

The following endophenotypes have been described:[5]

Criteria for valid animal models of depression

An appropriate animal model of human depression should fulfill the following criteria as much as possible: strong phenomenological similarities and similar pathophysiology (face validity), comparable etiology (construct validity), and common treatment (predictive validity).[6][7][8] Again, depression is a heterogeneous disorder and its many symptoms are hard to be produced in laboratory animals. The question therefore remains whether we can know the animal is "depressed". Actually, few models of depression fully fit these validating criteria, and most models currently used rely on either actions of known antidepressants or responses to stress. It is not necessary for an "ideal" animal model of depression to exhibit all the abnormalities of depression-relevant behaviors, just as not all patients manifest every possible symptom of depression.

Antidepressant screening tests

Antidepressant screening tests, not like the models which can be defined as an [organism] or a particular state of an organism that reproduces aspects of human pathology, provide only an end-point behavioral or physiological measure designed to assess the effect of the genetic, pharmacological, or environmental manipulation.

Despair-based

Forced-swimming test
The advantages of FST are that it is low-costing and is a fast and reliable tool, easy to handle and has proven its reliability across laboratories, for testing potential antidepressants activities with a strong predictive validity. Besides, it allows rapid screening of large numbers of drugs. The major disadvantages of FST are that it has poor face and construct validities. The test is sensitive to acute treatment only, and its validity for non-monoamine antidepressants is uncertain
Tail suspension test
A major advantage of the TST is that it is simple and inexpensive. A major disadvantage of the TST is that it is restricted to mice and limited to strains that do not tend to climb their tail. Besides, like FST, TST is sensitive to acute treatment only, and its validity for non-monoamine antidepressants is uncertain.

Reward-based

Open field

Anxiety-based

Elevated plus maze
Dark/light box

Stress models

Certain types of human depression are precipitated by stressful life events, and vulnerable individuals experiencing these stressors may develop clinical depression. Consequently, the majority of animal models of depression are based on the exposure to various types of acute or chronic stressors.

Adult stress models

An advantage of LH is that the cognitive and other behavioral outcomes seem to be correlated, thus helping to understand the depressive symptomatology in humans. Besides, this model can also be generally used to measure the escape performance of mice with different mutations, in which target genes of depression may affect the vulnerability to develop a depressive-like state. These excellent face and predictive validities make LH an interesting model to explore the pathophysiology of depression. The biggest disadvantage of LH is it requires very strong stressors to induce the behavioral phenotypes, which does raise ethical problems. Also, most of the symptoms do not persist long enough following cessation of the uncontrollable shock.
The advantages of this model are its good predictive validity (behavioral changes are reversed by chronic treatment with a wide variety of antidepressants), face validity (almost all demonstrable symptoms of depression have been reproduced), and construct validity (CMS causes a generalized decrease in responsiveness to rewards). However, there is a common practical difficulty in carrying out CMS experiments, which are labor intensive, demanding of space, and of long duration. Besides, the procedure can be difficult to be established and data can be hardly replicated.
Like CMS, SDS has good predictive validity (behavioral changes are reversed by chronic treatment with a wide variety of antidepressants), face validity (many symptoms of depression have been reproduced), and construct validity(causing a generalized decrease in responsiveness to rewards) and gives another validity that only chronic but not acute antidepressant administration can reverse the social aversion. One disadvantage of SDS model is the long duration. To apply SDS model for studying human depression, the period of it should last at least 20 days otherwise only anxiety symptoms could be induced. Worthy of note, only male rodents can be used for this model, since female rodents do not fight each other in a resident–intruder confrontation.

Early life stress models

Early adverse experiences such as traumatic life events in childhood result in an increased sensitivity to the effects of stress later in life and influence the individual vulnerability to depression.[27] Suitable animal models could provide a basis for understanding potential mechanisms of environmental and developmental factors of individual differences in stress reactivity and vulnerability to disorders. Models of early life stress involve prenatal stress, early postnatal handling and maternal separation. All these treatments have been demonstrated to produce significant effects that last until adulthood.

Other models

See also

References

  1. NIMH: Depression
  2. Kessler, R.C., et al., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry, 2005. 62(6): p. 593-602.
  3. Murray, C.J. and Lopez, A.D. (1997) Alternative projections of mortalityand disability by cause 1990–2020: Global Burden of Disease Study. Lancet349, 1498–1504
  4. Hua-Cheng YAN, Xiong CAO, Manas Das, Xin-Hong ZHU, Tian-Ming GAO. 2010. "Behavioral animal models of depression" Neurosci Bull August 1, 2010, 26(4): 327-337
  5. 1 2 Hasler, G. et al. (2004) Discovering endophenotypes for major depression. Neuropsychopharmacology 29, 1765–1781
  6. Willner P, Mitchell PJ. The validity of animal models of predisposition to depression. Behav Pharmacol 2002, 13: 169-188.
  7. Anisman H, Matheson K. Stress, depression, and anhedonia:caveats concerning animal models. Neurosci Biobehav Rev 2005,29: 525-546.
  8. Vollmayr B, Mahlstedt MM, Henn FA. Neurogenesis and depression: what animal models tell us about the link. Eur ArchPsychiatry Clin Neurosci 2007, 257: 300-303.
  9. Benoit Petit-Demouliere, Franck Chenu, Michel Bourin. Forced swimming test in mice: a review of antidepressant activity Psychopharmacology (2005) 177: 245–255
  10. Cryan JF, Mombereau C, Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev2005, 29: 571-625.
  11. 1 2 Christina Kurre Nielsen, Jorn Arnt, Connie Sánchez Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences Behavioural Brain Research Volume 107, Issues 1-2, January 2000, Pages 21-33
  12. Dulawa, S.C. and Hen, R. (2005) Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci. Biobehav. Rev. 29, 771–783
  13. 1 2 3 Holmes, A. (2001) Targeted gene mutation approaches to the study of anxiety-like behavior in mice. Neurosci. Biobehav. Rev. 25,261–273
  14. Drugan RC, Basile AS, Ha JH, Healy D, Ferland RJ. Analysis of the importance of controllable versus uncontrollable stress on subsequent behavioral and physiological functioning. Brain Res Brain Res Protoc 1997, 2: 69-74.
  15. Grahn RE, Watkins LR, Maier SF. Impaired escape performance and enhanced conditioned fear in rats following exposure to an uncontrollable stressor are mediated by glutamate and nitric oxide in the dorsal raphe nucleus. Behav Brain Res 2000, 112: 33-41.
  16. Durgam RC. Rodent models of depression: learned helplessness using a triadic design in rats. Curr Protoc Neurosci 2001, Chapter 8: Unit 8 10B.
  17. Chourbaji S, Zacher C, Sanchis-Segura C, Dormann C, Vollmayr B, Gass P. Learned helplessness: validity and reliability of depressive- like states in mice. Brain Res Brain Res Protoc 2005, 16: 70-78
  18. Vollmayr B, Henn FA. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc 2001, 8: 1-7.
  19. Willner, P. (2005) Chronic mild stress (CMS) revisited: consistency andbehavioral-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90–110
  20. Willner P, Muscat R, Papp M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 1992, 16: 525-534.
  21. Monleon S, D’Aquila P, Parra A, Simon VM, Brain PF, Willner P. Attenuation of sucrose consumption in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology (Berl) 1995, 117: 453-457
  22. Stemmelin J, Cohen C, Yalcin I, Keane P, Griebel G. Implication of [beta]3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress. Behav Brain Res 2010, 206: 310-312.
  23. Blanchard, R.J. et al. (2001) Animal models of social stress: effects on behavior and brain neurochemical systems. Physiol Behav. 73, 261–271
  24. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007, 131: 391-404.
  25. Cryan JF, Slattery DA. Animal models of mood disorders: Recent developments. Curr Opin Psychiatry 2007, 20: 1-7.
  26. Kudryavtseva NN, Bakshtanovskaya IV, Koryakina LA. Social model of depression in mice of C57BL/6J strain. Pharmacol Biochem Behav 1991, 38: 315-320
  27. McEwen, B.S. (2003) Early life influences on life-long patterns of behavior and health. Ment. Retard. Dev. Disabil. Res. Rev. 9, 149–154
  28. Meaney, M.J. (2001) Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Annu. Rev.Neurosci. 24, 1161–1192
  29. Song, C. and Leonard, B.E. (2005) The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 29, 627–647
  30. O’Neil, M.F. and Moore, N.A. (2003) Animal models of depression: are there any? Hum. Psychopharmacol. 18, 239–254
  31. Schramm NL, McDonald MP, Limbird LE. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. J Neurosci 2001, 21: 4875- 4882.
  32. Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, et al. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 2005, 25: 6243-6250.
  33. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 2001, 21: 7397-7403.
  34. Bucan, M. and Abel, T. (2002) The mouse: genetics meets behavior. Nat.Rev. Genet. 3, 114–123
This article is issued from Wikipedia - version of the 8/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.